-
Taxonomy & unit
-
us-gaap: shares
-
Description
-
Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period.
-
Summary
-
Adaptimmune Therapeutics PLC quarterly/annual Weighted Average Number of Shares Outstanding, Basic history and growth rate from Q3 2017 to Q3 2024.
- Adaptimmune Therapeutics PLC Weighted Average Number of Shares Outstanding, Basic for the quarter ending September 30, 2024 was 1.53B shares, a 13% increase year-over-year.
- Adaptimmune Therapeutics PLC annual Weighted Average Number of Shares Outstanding, Basic for 2023 was 1.21B shares, a 24.7% increase from 2022.
- Adaptimmune Therapeutics PLC annual Weighted Average Number of Shares Outstanding, Basic for 2022 was 967M shares, a 3.47% increase from 2021.
- Adaptimmune Therapeutics PLC annual Weighted Average Number of Shares Outstanding, Basic for 2021 was 935M shares, a 9.37% increase from 2020.
Weighted Average Number of Shares Outstanding, Basic, Quarterly (shares)
Weighted Average Number of Shares Outstanding, Basic, YoY Quarterly Growth (%)